{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:06:25Z","timestamp":1795017985187,"version":"4.10.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Development Fund of Tianjin Education Commission for Higher Educatio"},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCQNJC79500"],"award-info":[{"award-number":["18JCQNJC79500"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173199"],"award-info":[{"award-number":["82173199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer-associated fibroblasts (CAFs) are one of the most enriched components of Hepatocellular carcinoma (HCC) microenvironment, which are tightly related to the metastasis and invasion of HCC. We identified a mechanism by which CAF-derived chemokine CCL5 enhanced HCC metastasis by triggering the HIF1\u03b1\/ZEB1 axis. We demonstrated that CAFs derived from HCC tissues promoted the migration and invasion of HCC cells and facilitated metastasis to the lung of NOD\/SCID mice. Then the chemokine antibody array elucidated the higher chemokine CCL5 level secreted by CAFs than by paracancerous tissue fibroblasts (PTFs). Mechanistically, we found that CAF-derived CCL5 inhibited the ubiquitination and degradation of hypoxia-inducible factor 1 alpha (HIF1\u03b1) by binding to specific receptors, maintained HIF1\u03b1 under normoxia, thereby up-regulated the downstream gene zinc finger enhancer-binding protein 1 (ZEB1) and induced epithelial-mesenchymal transition (EMT), ultimately validating its ability to promote lung metastasis of HCC. And this novel mechanism may have association with poor prognosis. Taken together, targeting CAF-derived CCL5 mediated HIF1\u03b1\/ZEB1 cascade possibly propose a new therapeutic route for HCC.<\/jats:p>","DOI":"10.1038\/s41419-022-04935-1","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T23:32:14Z","timestamp":1653003134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Cancer associated fibroblast\u2013derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis"],"prefix":"10.1038","volume":"13","author":[{"given":"Haixu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-0731","authenticated-orcid":false,"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-1807","authenticated-orcid":false,"given":"Qiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"4935_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1047-6","volume":"18","author":"C Lu","year":"2019","unstructured":"Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, et al. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 2019;18:130.","journal-title":"Mol Cancer"},{"key":"4935_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","volume":"30","author":"P Gascard","year":"2016","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016;30:1002\u201319.","journal-title":"Genes Dev"},{"key":"4935_CR3","doi-asserted-by":"crossref","unstructured":"Procacci P, Moscheni C, Sartori P, Sommariva M, Gagliano N. Tumor- Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential. Cells. 2018;7:158.","DOI":"10.3390\/cells7100158"},{"key":"4935_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2017","unstructured":"Affo S, Yu LX, Schwabe RF. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol. 2017;12:153\u201386.","journal-title":"Annu Rev Pathol"},{"key":"4935_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2016.05.022","volume":"379","author":"J Liu","year":"2016","unstructured":"Liu J, Chen S, Wang W, Ning BF, Chen F, Shen W, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-\u03b2 pathways. Cancer Lett. 2016;379:49\u201359.","journal-title":"Cancer Lett"},{"key":"4935_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.biopha.2012.02.001","volume":"66","author":"ZY Lin","year":"2012","unstructured":"Lin ZY, Chuang YH, Chuang WL. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells. Biomed Pharmacother. 2012;66:525\u20139.","journal-title":"Biomed Pharmacother"},{"key":"4935_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2019.10.029","volume":"469","author":"T Gao","year":"2020","unstructured":"Gao T, Zhang X, Zhao J, Zhou F, Wang Y, Zhao Z, et al. SIK2 promotes reprogramming of glucose metabolism through PI3K\/AKT\/HIF-1\u03b1 pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Cancer Lett. 2020;469:89\u2013101.","journal-title":"Cancer Lett"},{"key":"4935_CR8","unstructured":"Sun JY, Chen XY, Wang L, Ye WX, Shen SJ, Yang JL. et al. [Hypoxia-inducible factor-1\u03b1 mediates and regulates angiogenesis-related factors expression in hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2020;28:942\u20138.."},{"key":"4935_CR9","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3892\/ijo.2015.3202","volume":"47","author":"Y Du","year":"2015","unstructured":"Du Y, Long Q, Zhang L, Shi Y, Liu X, Li X, et al. Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA\/mTOR\/HIF-1\u03b1 signaling. Int J Oncol. 2015;47:2064\u201372.","journal-title":"Int J Oncol"},{"key":"4935_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ebiom.2019.05.008","volume":"44","author":"S Zhao","year":"2019","unstructured":"Zhao S, Yao K, Li D, Liu K, Jin G, Yan M, et al. Inhibition of LTA4H by bestatin in human and mouse colorectal cancer. EBioMedicine 2019;44:361\u201374.","journal-title":"EBioMedicine"},{"key":"4935_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5:402\u201318.","journal-title":"Acta Pharm Sin B."},{"key":"4935_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1196-y","volume":"15","author":"CH Sukowati","year":"2015","unstructured":"Sukowati CH, Anfuso B, Croc\u00e9 LS, Tiribelli C. The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis. BMC Cancer. 2015;15:188.","journal-title":"BMC Cancer"},{"key":"4935_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-019-0782-x","volume":"12","author":"Z Yin","year":"2019","unstructured":"Yin Z, Dong C, Jiang K, Xu Z, Li R, Guo K, et al. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. J Hematol Oncol. 2019;12:101.","journal-title":"J Hematol Oncol"},{"key":"4935_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.03.004","volume":"397","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li X, Sun W, Yue S, Yang J, Li J, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33\u201342.","journal-title":"Cancer Lett"},{"key":"4935_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"4935_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jcmgh.2018.12.009","volume":"7","author":"L Chen","year":"2019","unstructured":"Chen L, Gu J, Qian Y, Li M, Qian Y, Xu M, et al. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity. Cell Mol Gastroenterol Hepatol. 2019;7:623\u201339.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4935_CR17","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1172\/JCI41732","volume":"120","author":"ML Berres","year":"2010","unstructured":"Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H, et al. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest. 2010;120:4129\u201340.","journal-title":"J Clin Invest"},{"key":"4935_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557\u201363.","journal-title":"Nature."},{"key":"4935_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/carcin\/bgr009","volume":"32","author":"Z Mi","year":"2011","unstructured":"Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011;32:477\u201387.","journal-title":"Carcinogenesis."},{"key":"4935_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/15384047.2017.1373219","volume":"18","author":"T Yang","year":"2017","unstructured":"Yang T, Chen M, Yang X, Zhang X, Zhang Z, Sun Y, et al. Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5\/CCR5 axis. Cancer Biol Ther. 2017;18:806\u201315.","journal-title":"Cancer Biol Ther"},{"key":"4935_CR21","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.18632\/aging.202803","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang J, Han L, Yu J, Li H, Li Q. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3\/AMPK\/mTOR\/HIF-1\u03b1 axis. Aging (Albany NY). 2021;13:10431\u201349.","journal-title":"Aging (Albany NY)"},{"key":"4935_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40675-017-0062-7","volume":"3","author":"JC Jun","year":"2017","unstructured":"Jun JC, Rathore A, Younas H, Gilkes D, Polotsky VY. Hypoxia-Inducible Factors and Cancer. Curr Sleep Med Rep. 2017;3:1\u201310.","journal-title":"Curr Sleep Med Rep"},{"key":"4935_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","volume":"78","author":"J Caramel","year":"2018","unstructured":"Caramel J, Ligier M, Puisieux A. Pleiotropic Roles for ZEB1 in Cancer. Cancer Res. 2018;78:30\u20135.","journal-title":"Cancer Res"},{"key":"4935_CR24","first-page":"3482","volume":"15","author":"J Zhu","year":"2018","unstructured":"Zhu J, Huang Z, Zhang M, Wang W, Liang H, Zeng J, et al. HIF-1\u03b1 promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model. Oncol Lett. 2018;15:3482\u20139.","journal-title":"Oncol Lett"},{"key":"4935_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","volume":"359","author":"JV Joseph","year":"2015","unstructured":"Joseph JV, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens-Meijer E, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis. Cancer Lett. 2015;359:107\u201316.","journal-title":"Cancer Lett"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04935-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:53:34Z","timestamp":1669283614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04935-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04935-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}